Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

NCT00887653 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV
Hyperlipidemia
Hypertriglyceridemia
HIV Infections

Interventions

DRUG: raltegravir

Sponsor

The Miriam Hospital

Collaborators

[object Object]
[object Object]